Subscribe To
Molecular templates announces participation in upcoming conferences
AUSTIN, Texas, March 01, 2023 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stag...
March 1, 2023, 4:44 pm
Cti biopharma to present at the 43rd annual cowen health care conference
SEATTLE , March 1, 2023 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical...
March 1, 2023, 4:20 pm
Dynavax to present at the cowen 43rd annual health care conference
EMERYVILLE, Calif. , March 1, 2023 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage bio...
March 1, 2023, 4:15 pm
Pharma stock surges after fda approves treatment
The shares of Reata pharmaceuticals Inc (NASDAQ:RETA) are up 178.5% at $86.81 this afternoon, after ...
March 1, 2023, 2:30 pm
Why shares of amphastar pharmaceuticals rose today
The company reported a record revenue year and increased EPS....
March 1, 2023, 1:54 pm
Reata pharmaceuticals wins key fda approval for rare disease treatment friedreich's ataxia, sending shares soaring
Biopharma company Reata pharmaceuticals Inc (NASDAQ:RETA) was in the spotlight on Wednesday after a ke...
March 1, 2023, 12:23 pm
Applied therapeutics to present at the cowen 43rd annual health care conference
NEW YORK, March 01, 2023 (GLOBE NEWSWIRE) — Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biop...
March 1, 2023, 12:00 pm
Eli lilly to cut insulin prices by 70%
Eli Lilly and Co (NYSE:LLY) announced it is reducing the price of most of its commonly prescribed insulins by 70% and the expansion of its Insulin Val...
March 1, 2023, 11:43 am
Therma bright appoints inhaled drug pioneer dr john patton as chairman of instatin
Therma Bright Inc (TSX-V:THRM, OTC:TBRIF), a developer and investor in a range of proprietary diagnostic and medical technologies, revealed that indus...
March 1, 2023, 10:11 am
Rhythm pharmaceuticals, inc. (rytm) reports q4 loss, tops revenue estimates
Rhythm pharmaceuticals, Inc. (RYTM) delivered earnings and revenue surprises of 8.54% and 24.56%, respe...
March 1, 2023, 9:47 am
Reata's stock jumps 175% in premarket trading after fda approval
Shares of Reata pharmaceuticals Inc. RETA soared about 175% in premarket trading on Wednesday, the day ...
March 1, 2023, 8:06 am
Catalyst pharmaceuticals to report fourth quarter and full-year 2022 financial results on march 15, 2023
The Company Will Host a Conference Call and Webcast on March 16, 2023, at 8:30 AM ET The Company Will Host a Conference Call and Webcast on March 16, ...
March 1, 2023, 8:03 am
Stocks in focus: reata pharmaceuticals stock soars after fda-drug approval; novavax falls after vaccine maker issues ‘substantial doubts' over future operations
Here are U.S. stocks in focus ahead of Wednesday's trading session:...
March 1, 2023, 7:33 am
Reata soars on approval for rare disorder drug. its pipeline impresses analysts.
The FDA approves the pharmaceutical company's treatment for Friedreich's ataxia, which Citi analysts ex...
March 1, 2023, 7:14 am
Astrazeneca refinances $2.25bn of debt
AstraZeneca PLC (LSE:AZN), the UK's largest pharmaceuticals group, has announced a $2.25bn global bond...
March 1, 2023, 3:11 am
Rosen, national trial lawyers, encourages phathom pharmaceuticals, inc. investors to inquire about securities class action investigation – phat
NEW YORK, Feb. 28, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securiti...
March 1, 2023, 12:38 am
Atea pharmaceuticals, inc. (avir) q4 2022 earnings call transcript
Atea pharmaceuticals, Inc. (NASDAQ:AVIR ) Q4 2022 Earnings Conference Call February 28, 2023 4:30 PM ET...
February 28, 2023, 10:14 pm
Supernus pharmaceuticals, inc. (supn) q4 2022 earnings call transcript
Supernus pharmaceuticals, Inc. (NASDAQ:SUPN ) Q4 2022 Earnings Conference Call February 28, 2023 4:30 P...
February 28, 2023, 9:33 pm
Amphastar pharmaceuticals, inc. (amph) q4 2022 earnings call transcript
Amphastar pharmaceuticals, Inc. (NASDAQ:AMPH ) Q4 2022 Earnings Conference Call February 28, 2023 5:00 ...
February 28, 2023, 9:15 pm
Ngm biopharmaceuticals (ngm) reports q4 loss, tops revenue estimates
NGM Biopharmaceuticals (NGM) delivered earnings and revenue surprises of 13.46% and 166.31%, respective...
February 28, 2023, 8:20 pm